Navigation Links
Revisions needed for current IV feeding safeguards against bloodstream infections
Date:6/25/2014

Current guidelines to help prevent bloodstream infections during intravenous feeding may need revisions to strengthen protections for patients, a new study finds.

Researchers at the United Kingdom's University of Southampton found that current guidelines do not account for other independent factors that can affect the growth of potentially deadly microorganisms. Their study was published today in the OnlineFirst version of the Journal of Parenteral and Enteral Nutrition (JPEN), the research journal of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).

Existing guidelines restrict how long a single bag of parenteral nutrition (PN) containing lipids can be used due to the ability of lipids to encourage the growth of microorganisms. This study looked at the growth of Escherichia coli (E coli) and Enterococcus durans (E durans) in PN to see if other factors can affect microbial growth.

The study found that additional factors, including glucose concentration, proportion of glucose to lipid, and osmolarity (concentration of a solution that can pass through the wall of a living cell through osmosis), can affect microbial growth apart from the presence of lipids.

The study's researchers recommend that these additional factors should be considered when making clinical and policy decisions to limit the potential growth of microorganisms in PN.


'/>"/>

Contact: Troy Petenbrink
media@nutritioncare.org
202-297-1703
American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
Source:Eurekalert

Page: 1

Related medicine news :

1. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
2. New guidelines and technology needed for placement of feeding tubes in pediatric patients
3. More maternal mental health surveillance is needed, suggests new study
4. Different approaches needed to control cardiovascular disease risks for those with HIV
5. National coordination needed to advance convergent research
6. The Lancet Diabetes & Endocrinology: Large clinical trials to evaluate risks of testosterone treatment urgently needed
7. Standardized evaluation consent forms for living liver donors needed
8. New approach to prostate cancer screening needed
9. One in 5 US hospitals dont put hand sanitizer everywhere needed to prevent infections
10. Tighter economic regulation needed to reverse obesity epidemic -- study
11. Physical Assessments: No Appointment Needed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: